drugset / Trial / NCT01047436

Efficacy of ArTiMist™ in Children

NCT01047436

Phase 2 Completed 31 enrolled Proto Pharma Ltd Xidea Solutions Limited · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy of Artemether Sublingual Spray (ArTiMist™) with intravenous quinine in children with severe or complicated falciparum malaria, or children with uncomplicated malaria with gastrointestinal complications.

Timeline

Start
2009-12
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether Small molecule 3 mg/kg Other
Comparator Quinine Small molecule 10 mg/kg Intravenous